Committed to providing whole-life-cycle medical services for domestic and foreign pharmaceutical companies, including clinical trials register, post-marketing clinical study and real world study. According to the characteristics of the drug and its life cycle, we provide medical services such as medical strategy, medical writing, and medical monitoring.
BRAF V600E inhibitor Phase I, Phase II clinical research plan writing,
medical monitoring, CSR writing
The first Phase IV clinical study of the long-acting rhG-CSF in China,
medical strategy, medical writing
Chinese and English standard operating procedures and excellent quality management system; participating in more than 100 Phase I-IV clinical studies, with rich experience in pre-marketing/post-marketing clinical studies involving various disease areas, such as tumor, anti-infection, etc.